See also this year's filing and all EDGAR filings for this company.
PDF Report 0001576280_2023_Guardant_Health_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.013457487280086541, 'aggregate_val': 587403000, 'exp_sum': 579603000, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 2046000, 'AssetsCurrent': 468991000, 'PropertyPlantAndEquipment': 31003000, 'remainder_Assets': 77563000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001576280, Guardant Health Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 15,017,000 |
| 1 | AssetsNonCurrent | 235,454,000 |
| 2 | AssetsCurrent | 1,191,594,000 |
| 3 | PropertyPlantAndEquipment | 167,920,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 1,356,585,000 |
| 6 | LiabilitiesCurrent | 193,220,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 163,956,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 299,828,000 |
| 15 | ResearchAndDevelopmentExpense | 373,807,000 |
| 16 | remainder_Expenses | 160,041,000 |
| 17 | remainder_Revenues | 449,538,000 |
| 18 | remainder_NetIncome | -106,494,000 |
| 19 | remainder_ComprehensiveNetIncome | -14,758,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,609,985,000 |
| 1 | Liabilities | 1,549,805,000 |
| 2 | Expenses | 997,632,000 |
| 3 | Revenues | 449,538,000 |
| 4 | StockholdersEquity | 60,180,000 |
| 5 | NetIncome | -654,588,000 |
| 6 | ComprehensiveNetIncome | -669,346,000 |
| 7 | BaseVar | 2,364,106,000 |
| 8 | EconomicCapitalRatio | -0.318 |
Edgar->Model Mapping
Feature Distribution
Change over Time
